Imatinib Improves but May Not Fully Reverse the Poor Prognosis of Patients With CML With Derivative Chromosome 9 Deletions
Blood - United States
doi 10.1182/blood-2002-09-2763
Full Text
Open PDFAbstract
Available in full text
Date
September 15, 2003
Authors
Publisher
American Society of Hematology